+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Statins Market by Type (Natural Statins, Synthetic Statins), Drug Class (Atorvastatin, Fluvastatin, Lovastatin), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889867
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Statins Market size was estimated at USD 31.61 billion in 2023, USD 33.30 billion in 2024, and is expected to grow at a CAGR of 5.85% to reach USD 47.08 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Statins Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Statins Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Statins Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Amgen Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Becton, Dickinson and Company, Biocon Limited, bioMérieux S.A., Centrient Pharmaceuticals Netherlands B.V., Concord Biotech Limited, Danaher Corporation, DiaSorin S.p.A., F. Hoffman-La Roche AG, GlaxoSmithKline PLC, Grifols, S.A., Merck & Co., Inc., Nova Biomedical, Novartis AG, Pfizer Inc., Quidel Corporation, Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Statins Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Natural Statins
    • Synthetic Statins
  • Drug Class
    • Atorvastatin
    • Fluvastatin
    • Lovastatin
    • Pitavastatin
    • Rosuvastatin
    • Simvastatin
  • Application
    • Attacks
    • Cardiovascular Diseases
    • Diabetes
    • Heart Strokes
    • Inflammation
    • Lifestyle Diseases
    • Obesity
  • End-User
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Statins Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Statins Market?
  3. What are the technology trends and regulatory frameworks in the Statins Market?
  4. What is the market share of the leading vendors in the Statins Market?
  5. Which modes and strategic moves are suitable for entering the Statins Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Statins Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the incidence of chronic diseases globally
5.1.1.2. Rising consumer preference for over-the-counter (OTC) drugs
5.1.1.3. Escalating demand for statins due to increasing consumer awareness about maintaining a healthy lifestyle
5.1.2. Restraints
5.1.2.1. Increasing preference for alternative medicines in emerging economies
5.1.3. Opportunities
5.1.3.1. Growth in R&D activities for newer statin development
5.1.3.2. Emerging demand for affordable and effective cholesterol-maintaining solutions
5.1.4. Challenges
5.1.4.1. Concerns associated with side-effects of statins
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Statins Market, by Type
6.1. Introduction
6.2. Natural Statins
6.3. Synthetic Statins
7. Statins Market, by Drug Class
7.1. Introduction
7.2. Atorvastatin
7.3. Fluvastatin
7.4. Lovastatin
7.5. Pitavastatin
7.6. Rosuvastatin
7.7. Simvastatin
8. Statins Market, by Application
8.1. Introduction
8.2. Attacks
8.3. Cardiovascular Diseases
8.4. Diabetes
8.5. Heart Strokes
8.6. Inflammation
8.7. Lifestyle Diseases
8.8. Obesity
9. Statins Market, by End-User
9.1. Introduction
9.2. Clinics
9.3. Hospitals
10. Americas Statins Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Statins Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Statins Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AccuBioTech Co., Ltd.
14.1.3. Amgen Inc.
14.1.4. AstraZeneca PLC
14.1.5. Aurobindo Pharma Ltd.
14.1.6. Becton, Dickinson and Company
14.1.7. Biocon Limited
14.1.8. bioMérieux S.A.
14.1.9. Centrient Pharmaceuticals Netherlands B.V.
14.1.10. Concord Biotech Limited
14.1.11. Danaher Corporation
14.1.12. DiaSorin S.p.A.
14.1.13. F. Hoffman-La Roche AG
14.1.14. GlaxoSmithKline PLC
14.1.15. Grifols, S.A.
14.1.16. Merck & Co., Inc.
14.1.17. Nova Biomedical
14.1.18. Novartis AG
14.1.19. Pfizer Inc.
14.1.20. Quidel Corporation
14.1.21. Siemens AG
14.1.22. Terumo Corporation
14.1.23. Thermo Fisher Scientific, Inc.
14.1.24. Trinity Biotech PLC
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. STATINS MARKET RESEARCH PROCESS
FIGURE 2. STATINS MARKET SIZE, 2023 VS 2030
FIGURE 3. STATINS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. STATINS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. STATINS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. STATINS MARKET DYNAMICS
FIGURE 7. STATINS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. STATINS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. STATINS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 10. STATINS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. STATINS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. STATINS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. STATINS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. STATINS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS STATINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS STATINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES STATINS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES STATINS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC STATINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC STATINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. STATINS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. STATINS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. STATINS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. STATINS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STATINS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. STATINS MARKET SIZE, BY NATURAL STATINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. STATINS MARKET SIZE, BY SYNTHETIC STATINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 9. STATINS MARKET SIZE, BY ATORVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. STATINS MARKET SIZE, BY FLUVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. STATINS MARKET SIZE, BY LOVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. STATINS MARKET SIZE, BY PITAVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. STATINS MARKET SIZE, BY ROSUVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. STATINS MARKET SIZE, BY SIMVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. STATINS MARKET SIZE, BY ATTACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. STATINS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. STATINS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. STATINS MARKET SIZE, BY HEART STROKES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. STATINS MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. STATINS MARKET SIZE, BY LIFESTYLE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. STATINS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. STATINS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. STATINS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS STATINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 41. CANADA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. MEXICO STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES STATINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC STATINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. CHINA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 63. CHINA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. CHINA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDIA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 67. INDIA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDIA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. JAPAN STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 75. JAPAN STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. JAPAN STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. THAILAND STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 99. THAILAND STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. THAILAND STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 112. DENMARK STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. DENMARK STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EGYPT STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 116. EGYPT STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. EGYPT STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FINLAND STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 120. FINLAND STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FINLAND STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. GERMANY STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 136. ITALY STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. NORWAY STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 148. NORWAY STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. NORWAY STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. POLAND STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 152. POLAND STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. POLAND STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. QATAR STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 156. QATAR STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. QATAR STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SPAIN STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. TURKEY STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 184. TURKEY STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM STATINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM STATINS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM STATINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM STATINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. STATINS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 195. STATINS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 196. STATINS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Amgen Inc.
  • AstraZeneca PLC
  • Aurobindo Pharma Ltd.
  • Becton, Dickinson and Company
  • Biocon Limited
  • bioMérieux S.A.
  • Centrient Pharmaceuticals Netherlands B.V.
  • Concord Biotech Limited
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffman-La Roche AG
  • GlaxoSmithKline PLC
  • Grifols, S.A.
  • Merck & Co., Inc.
  • Nova Biomedical
  • Novartis AG
  • Pfizer Inc.
  • Quidel Corporation
  • Siemens AG
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 33.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 47.08 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal

Related Topics

Related Reports

Statins - Global Strategic Business Report - Product Image

Statins - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Statin Market Report by Type, Therapeutic Area, Drug Class, Application, Distribution, and Region 2024-2032 - Product Image

Statin Market Report by Type, Therapeutic Area, Drug Class, Application, Distribution, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Statins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Statins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
Statin Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 - Product Image

Statin Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

  • Report
  • 190 Pages
  • Global
From
Statin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Statin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 77 Pages
  • Global
From

About the Statin Market

The Statin market is a subset of the Cardiovascular Drugs market, which includes medications used to treat and prevent heart disease. Statins are a type of drug used to lower cholesterol levels in the blood, reducing the risk of heart attack and stroke. They work by blocking an enzyme in the liver that is responsible for producing cholesterol. Statins are typically prescribed to people with high cholesterol levels, as well as those with a history of heart disease. Statin drugs are available in both generic and brand-name forms. Common brand-name statins include Lipitor, Crestor, and Zocor. Generic statins are also available, such as atorvastatin, rosuvastatin, and simvastatin. In addition to statins, other cardiovascular drugs include antihypertensives, anticoagulants, and antiarrhythmics. These drugs are used to treat and prevent a variety of heart-related conditions, such as high blood pressure, stroke, and arrhythmia. Some of the major companies in the Statin market include Pfizer, AstraZeneca, Merck, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.